Skip to main content

Table 1 Demographic data, clinical characteristic and blood biochemistry values of the studied groups

From: Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study

 

Patients (n = 35)

Control (n = 40)

p

Age (years)

32.29 ± 13.41 (18–65)

34.48 ± 12.98 (18–70)

0.47

Sex

 Female

20 (57.1%)

23 (57.5%)

0.98

 Male

15 (42.9%)

17 (42.5%)

 

CRP (mg/dl)

6.46 ± 4.9

5.28 ± 3.49

0.31

ESR (mm/h)

28.43 ± 18.47

17.73 ± 5.19

0.017*

Neutrophil 1 (103/mL)

82.01 ± 13.64

37.55 ± 11.39

< 0.001*

Neutrophil 2 (103/mL)

36.96 ± 10.62

 

0.82

Lymphocyte 1(103/mL)

22.59 ± 7.5

15.31 ± 5.34

< 0.001*

Lymphocytes 2(103/mL)

16.83 ± 3.83

0.17

NLR 1

3.95 ± 1.34

2.58 ± 0.85

< 0.001*

NLR 2

2.27 ± 0.76

 

0.10

Hughes disability scale score 1

3.28 ± 1.29

 

Hughes disability scale score 2

1.92 ± 1.77

 

History of infection:

 Yes

20 (57.1%)

 

 No

15 (42.9%)

 
  1. Data were expressed as number (N) and percentage (%),
  2. NLR1 neutrophil–lymphocyte ratio before plasmapheresis, NLR2 neutrophil–lymphocyte ratio after plasmapheresis, ESR erythrocyte sedimentation rate, CRP C-reactive protein
  3. * Statistically significant at p < 0.05